Home LiteratureArticle Details
PMID: 285734 Published · ppublish English Journal Article

Interrelationship of immunologic characteristics, proliferation pattern, and prednisone sensitivity in acute lymphoblastic leukemia of childhood.

Blood ·Vol. 53 ·No. 5 ·1979-05-00 ·Pages 883-91

Bakkeren JA, de Vaan GA, Hillen HF

Abstract

In children with acute lymphoblastic leukemia (ALL) the effect of prednisone therapy on the cell-cycle phase distribution of leukemic bone marrow cells was determined with pulse cytophotometry at the time of diagnosis. Also, the interrelationship with the presence of the sheep erythrocyte receptor as a marker for T cells was investigated. In 17 or 21 patients prednisone treatment caused a decrease in the percentage of cells in the S+G2+M phases. In 11 of 12 adult patients with ALL the same result was obtained. In a group of 31 children with ALL, 6 cases of T-cell ALL occurred in combination with intermediate or high WBC counts. The 3 patients with the highest E-rosetting percentages had rather high proportions of bone marrow cells in the S+G2+M phases. No correlation could be established between the WBC count or the E-rosetting percentage and the chance for complete remission.

MeSH Terms
Adolescent Adult Aged Cell Cycle Cell Division Cell Transformation, Neoplastic Child Child, Preschool Humans Infant Leukemia, Lymphoid/drug therapy,immunology Leukocyte Count Middle Aged Photometry Prednisone/therapeutic use Rosette Formation
Chemicals
Prednisone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bakkeren J A
de Vaan G A
Hillen H F
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1979-05-00
Pages
883-91
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com